KUALA LUMPUR (June 5): Bursa Malaysia Securities has given confinement centre and aesthetic clinic operator LYC Healthcare Bhd (KL:LYC) an extension until Nov 30, 2026 to submit its Guidance Note 3 (GN3) regularisation plan and obtain regulatory approval.
The board of LYC Healthcare, in a Bursa Malaysia filing on Friday, said the extension was approved by the regulator via a letter dated June 5, 2026.
LYC Healthcare was classified as an affected listed issuer under GN3 of the ACE Market Listing Requirements on May 30, 2025 after its shareholders’ equity fell below 25% of its issued share capital, based on its unaudited results for the financial period ended March 31, 2025.
Under GN3 rules, the company must submit a regularisation plan and obtain Bursa Securities’ approval within 12 months of the announcement, and implement the plan within six months after approval, or within 12 months if court proceedings are involved.
Bursa Securities said on Friday that the extension does not affect its right to suspend trading and delist the company if LYC Healthcare fails to submit its plan by the deadline, fails to secure approvals, or fails to implement the plan within the required timeframe.
In such cases, trading of LYC Healthcare’s securities will be suspended on the sixth market day after notification, followed by delisting, subject to the company’s right to appeal.
LYC Healthcare reported a wider net loss of RM23.27 million for the financial year ended March 31, 2026, compared with RM17.07 million a year earlier, due to higher operating costs and depreciation and amortisation expenses in its healthcare services segment, its main earnings contributor. This was on 14% lower revenue of RM134.19 million from RM155.52 million.
As at March 31, 2026, shareholders’ equity was about 53.2% of share capital. The company’s borrowings exceeded its cash holdings by RM52.47 million, putting it in a net debt position.
LYC Healthcare’s share price was untraded on Friday. At its last price of two sen, the company is valued at RM14.8 million.